@BharatBiotech Updates BBV154 Has Received Approval for Phase 3 ... - Latest Tweet by DD News
The latest Tweet by DD News states, '@BharatBiotech Updates BBV154 has received approval for phase 3 clinical trials. The trials will evaluate BBV154 nasal vaccine for both the 2 doses primary schedule and booster dose schedule. #CovidVaccine @tapasjournalist'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)